Articles
- An Overview Of The PTO Sequence Rules (37 CFR §§1.821-1.825)
- PTO Hearings On Patenting Of Nucleic Acid Sequences Hightlight Higher Costs And Other Examination Problems
- Ajinomoto Sues ADM Over Amino Acid Patent
- AMGEN Wins Summary Judgment Against Genetics Institute In Ongoing Erythropoietin Litigation
- Round Three: AMGEN Strikes Back By Suing Genetics Institute To Enforce Earlier Settlement Agreement
- EST'S And Partial Sequences: Repercussions For The Biotechnology Client